Innovent Biologics' Series D Round

Innovent Biologics raised a round of funding on November 29, 2016.

Innovent Biologics is a biopharmaceutical company in China focused on the development and manufacturing of complex, high-end biologics for both the Asian and global markets that meet EMEA and FDA/cGMP…

Articles about Innovent Biologics' Series D Round: